Results 181 to 190 of about 1,140,223 (331)
Renal cell carcinoma with cavoatrial ventricular involvement. [PDF]
McGovern L, Roy R, Rullan A.
europepmc +1 more source
By catalyzing FAM134B ubiquitination and activating ER‐phagy, AMFR alleviates progressive fibrosis and cardiac dysfunction by inhibiting the mTORC1 pathway. Consequently, these findings underscore the essential role of AMFR‐driven ER‐phagy in mitigating the progression of fibrotic responses, offering a potential therapeutic target for preventing heart ...
Zhixiang Wang+10 more
wiley +1 more source
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
D. Braun+34 more
semanticscholar +1 more source
Duplex Sonography and Doppler Evaluation of Renal Cell Carcinoma With Inferior Vena Cava Involvement [PDF]
Carol A. Krebs+2 more
openalex +1 more source
FM‐DEL1 and FM‐DEL2 are constructed by installing one or two sets of building blocks on a phenylalanine central scaffold. FM‐DELs are screened against markers of prostate, and renal cell carcinoma, and against an immunological target expressed on the surface of natural killer cells.
Francesca Migliorini+12 more
wiley +1 more source
Nephron preservation in the management of renal cell carcinoma. [PDF]
Lee AY+6 more
europepmc +1 more source
Inhibition of AMPKα Pathway by Podocyte GOLM1 Exacerbates Diabetic Nephrology in Mice
Podocyte Golgi membrane protein 1 interacts with epidermal growth factor receptor to inhibit peroxisome proliferator activated receptor γ, and then inactivates adenosine monophosphate activated protein kinase α pathway, which facilitates diabetes‐related inflammation, oxidative damage, apoptosis, and renal dysfunction.
Peng Xu+14 more
wiley +1 more source
Role of fructose in renal cell carcinoma progression. [PDF]
Miao J+6 more
europepmc +1 more source